- Home
- ALCE vs PMD Comparison
ALCE vs PMD Comparison
Compare ALCE & PMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCE
- PMD
- Stock Information
- Founded
- ALCE 2019
- PMD 1986
- Country
- ALCE United States
- PMD United States
- Employees
- ALCE N/A
- PMD N/A
- Industry
- ALCE Power Generation
- PMD Medical Specialities
- Sector
- ALCE Utilities
- PMD Health Care
- Exchange
- ALCE Nasdaq
- PMD Nasdaq
- Market Cap
- ALCE 13.9M
- PMD 13.3M
- IPO Year
- ALCE N/A
- PMD N/A
- Fundamental
- Price
- ALCE $2.64
- PMD $2.32
- Analyst Decision
- ALCE
- PMD
- Analyst Count
- ALCE 0
- PMD 0
- Target Price
- ALCE N/A
- PMD N/A
- AVG Volume (30 Days)
- ALCE 366.2K
- PMD 23.2K
- Earning Date
- ALCE 11-15-2024
- PMD 11-07-2024
- Dividend Yield
- ALCE N/A
- PMD N/A
- EPS Growth
- ALCE N/A
- PMD N/A
- EPS
- ALCE N/A
- PMD N/A
- Revenue
- ALCE N/A
- PMD $20,787,000.00
- Revenue This Year
- ALCE N/A
- PMD N/A
- Revenue Next Year
- ALCE N/A
- PMD N/A
- P/E Ratio
- ALCE N/A
- PMD N/A
- Revenue Growth
- ALCE N/A
- PMD N/A
- 52 Week Low
- ALCE $2.17
- PMD $1.63
- 52 Week High
- ALCE $62.75
- PMD $3.93
- Technical
- Relative Strength Index (RSI)
- ALCE 25.58
- PMD 52.93
- Support Level
- ALCE $2.17
- PMD $2.28
- Resistance Level
- ALCE $8.00
- PMD $2.35
- Average True Range (ATR)
- ALCE 0.72
- PMD 0.02
- MACD
- ALCE -0.10
- PMD -0.00
- Stochastic Oscillator
- ALCE 8.06
- PMD 41.67
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.
About PMD Psychemedics Corporation
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.